正海生物
(300653)
| 流通市值：27.25亿 | | | 总市值：27.25亿 |
| 流通股本：1.80亿 | | | 总股本：1.80亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 71,869,970.9 | 56,779,790.45 | 61,987,525.36 | 67,486,496.32 |
| 交易性金融资产 | 545,960,515.04 | 594,214,538.69 | 575,108,162.71 | 544,945,809.95 |
| 应收票据及应收账款 | 59,363,311.95 | 58,965,680.69 | 57,176,037.65 | 57,821,391.78 |
| 其中：应收票据 | - | - | 0 | - |
| 应收账款 | 59,363,311.95 | 58,965,680.69 | 57,176,037.65 | 57,821,391.78 |
| 应收款项融资 | 2,923,050.6 | 2,180,637.7 | 1,418,132.8 | 736,310.4 |
| 预付款项 | 5,943,055.45 | 4,227,637.68 | 6,743,615.85 | 9,287,442.42 |
| 其他应收款合计 | 2,608,474.84 | 1,598,595.23 | 1,408,462.25 | 2,233,538.95 |
| 存货 | 32,947,860 | 31,533,321.1 | 29,550,070.29 | 29,664,271.05 |
| 其他流动资产 | 61,664.21 | - | - | - |
| 流动资产合计 | 721,677,902.99 | 749,500,201.54 | 733,392,006.91 | 712,175,260.87 |
| 非流动资产: | | | | |
| 固定资产 | 205,576,553.78 | 209,401,950.68 | 213,655,812.81 | 215,655,656.68 |
| 在建工程 | 2,201,017.84 | 2,379,916.92 | 1,148,149.8 | 1,777,758.47 |
| 无形资产 | 29,039,418.2 | 29,350,326.43 | 29,961,947.75 | 30,558,318.27 |
| 递延所得税资产 | 1,915,426.01 | 1,162,441.11 | 1,167,935.46 | 1,883,583.19 |
| 其他非流动资产 | 9,312,005.21 | 11,095,565.22 | 5,293,603.11 | 2,801,565 |
| 非流动资产合计 | 248,044,421.04 | 253,390,200.36 | 251,227,448.93 | 252,676,881.61 |
| 资产总计 | 969,722,324.03 | 1,002,890,401.9 | 984,619,455.84 | 964,852,142.48 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 20,549,715.43 | 22,287,635.94 | 15,869,632.19 | 12,074,965.69 |
| 其中：应付票据 | 5,091,426.91 | 5,091,426.91 | - | - |
| 应付账款 | 15,458,288.52 | 17,196,209.03 | 15,869,632.19 | 12,074,965.69 |
| 合同负债 | 9,175,861.45 | 10,370,747.32 | 11,190,944.5 | 8,076,066.9 |
| 应付职工薪酬 | 9,776,041.94 | 11,648,407.35 | 14,011,788.92 | 17,020,474.41 |
| 应交税费 | 7,069,751.61 | 6,179,200.65 | 6,723,278.84 | 6,485,681.76 |
| 其他应付款合计 | 39,190,023.7 | 38,005,943.75 | 36,813,785.61 | 36,299,079.01 |
| 其他流动负债 | 370,743.24 | 526,078.29 | 632,703.93 | 143,902.7 |
| 流动负债合计 | 86,132,137.37 | 89,018,013.3 | 85,242,133.99 | 80,100,170.47 |
| 非流动负债: | | | | |
| 递延收益 | 5,483,498.04 | 5,611,453.2 | 5,731,611.36 | 4,686,565.76 |
| 递延所得税负债 | 5,059,901.31 | 4,031,780.44 | 4,165,824.05 | 5,593,455.67 |
| 非流动负债合计 | 10,543,399.35 | 9,643,233.64 | 9,897,435.41 | 10,280,021.43 |
| 负债合计 | 96,675,536.72 | 98,661,246.94 | 95,139,569.4 | 90,380,191.9 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 180,000,000 | 180,000,000 | 180,000,000 | 180,000,000 |
| 资本公积 | 169,418,284.73 | 169,418,284.73 | 169,418,284.73 | 169,418,284.73 |
| 减:库存股 | 49,920,352.99 | 49,920,352.99 | 49,920,352.99 | 49,920,352.99 |
| 盈余公积 | 99,202,234.55 | 99,202,234.55 | 99,202,234.55 | 99,202,234.55 |
| 未分配利润 | 474,346,621.02 | 505,528,988.67 | 490,779,720.15 | 475,771,784.29 |
| 归属于母公司股东权益合计 | 873,046,787.31 | 904,229,154.96 | 889,479,886.44 | 874,471,950.58 |
| 股东权益合计 | 873,046,787.31 | 904,229,154.96 | 889,479,886.44 | 874,471,950.58 |
| 负债和股东权益合计 | 969,722,324.03 | 1,002,890,401.9 | 984,619,455.84 | 964,852,142.48 |
| 公告日期 | 2026-08-25 | 2026-04-18 | 2026-03-31 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |